Viewing Study NCT03438318


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2025-12-26 @ 3:56 AM
Study NCT ID: NCT03438318
Status: COMPLETED
Last Update Posted: 2022-08-03
First Post: 2018-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module